SIKIRATU OLAWUNMI: Open Payments
NPI 1598398778 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 22 payments from 9 companies in 2025. Trend: 2023 $881 · 2024 $1,198 · 2025 $699
Food & beverage: $654Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $206 |
| SOBI, INC | 3 | $103 |
| AstraZeneca Pharmaceuticals LP | 3 | $98 |
| Lilly USA, LLC | 3 | $77 |
| ABBVIE INC. | 2 | $66 |
| Incyte Corporation | 2 | $58 |
| Syndax Pharmaceuticals, Inc. | 1 | $35 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $26 |
Products named: CALQUENCE, Cresemba, JAYPIRCA, Vonjo, EPKINLY, Xospata, JAKAFI, TAVALISSE.
Industry payments across TX — which companies pay providers there.
